Opexa Therapeutics (OPXA) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Weighted avg shares outstanding - Basic and diluted: 7.07M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Weighted avg shares outstanding - Basic and diluted: 7.07M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Opexa Therapeutics (NASDAQ: OPXA) reported Q2 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- First Watch (FWRG) PT Lowered to $15 at DA Davidson, Buy Rating Maintained
- LTC Properties (LTC) PT Raised to $52 at RBC Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
